Caldwell Sutter Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.26K | Hold |
23
| – | – | ﹤0.01% | 760 |
|
|
2025
Q1 | $1.63K | Hold |
23
| – | – | ﹤0.01% | 748 |
|
|
2024
Q4 | $1.51K | Sell |
23
-8
| -26% | -$526 | ﹤0.01% | 778 |
|
|
2024
Q3 | $2.18K | Hold |
31
| – | – | ﹤0.01% | 746 |
|
|
2024
Q2 | $2.55K | Hold |
31
| – | – | ﹤0.01% | 726 |
|
|
2024
Q1 | $2.71K | Hold |
31
| – | – | ﹤0.01% | 713 |
|
|
2023
Q4 | $2.99K | Hold |
31
| – | – | ﹤0.01% | 700 |
|
|
2023
Q3 | $2.74K | Hold |
31
| – | – | ﹤0.01% | 687 |
|
|
2023
Q2 | $2.69K | Buy |
31
+23
| +288% | +$1.99K | ﹤0.01% | 694 |
|
|
2023
Q1 | $778 | Buy |
+8
| New | +$778 | ﹤0.01% | 538 |
|